The role of medullary thymic epithelial cell-derived growth factors in regulating thymus growth and atrophy
Project Number1R21AG081709-01
Contact PI/Project LeaderGRIFFITH, ANN VENABLES
Awardee OrganizationUNIVERSITY OF TEXAS HLTH SCIENCE CENTER
Description
Abstract Text
Summary
T lymphocytes are critical mediators of the adaptive immune response, however, they are continuously lost
throughout the lifespan, and therefore must be continuously replaced. The thymus is the primary site of new T
cell generation, and the unique thymic stromal microenvironment directs T cell differentiation, self-tolerance and
self-restriction. However, the size of the thymus declines precipitously beginning relatively early in life, resulting
in declining production of new, naïve T cells. As a result, homeostatic mechanisms driven expansion of memory
cells in the periphery, driving a shift toward an oligoclonal T cell memory, leaving the elderly less responsive to
vaccines and new infections, especially viral infections. Preventing or reversing age-associated thymic atrophy
therefore hold great potential for extending the healthspan in the aging population. The mechanisms governing
thymic atrophy have been difficult to identify, because the primary targets of atrophy, cortical thymic stromal
cells, are rare and difficult to isolate. To understand these mechanisms, we have applied an informatic approach
to characterize the transcriptional response of thymic stromal cells during age-related atrophy or experimentally
induced regeneration. We found that paracrine signaling between medullary and cortical epithelial cells (TECs),
particularly involving the mammalian target of rapamycin (mTOR) pathway, was likely to play a key role in the
mechanisms of atrophy and regeneration. To develop tools required test the hypothesis mTEC-derived signals
(particularly FGF21) promote thymus growth, and to facilitate more extensive mechanistic studies of paracrine
regulation of thymus function, we recently identified a gene (LPO) that drives specific expression of mCherry in
most mTEC within the thymus. Here, we propose the generation of similar knock-in mice in which LPO drives
expression of Cre recombinase, allowing tissue-specific genetic manipulation of mTECs. We will also use the
newly generated model to investigate the role of mTEC-derived FGF21 using FGF21LoxP mice.
Public Health Relevance Statement
Narrative
The thymus atrophies precipitously beginning relatively early in life, resulting in declining production of new,
naïve T cells, driving a shift toward an oligoclonal T cell memory, leaving the elderly less responsive to vaccines
and new infections, especially viral infections. We recently showed that paracrine signaling between medullary
and cortical thymic epithelial cells (TEC) involving the mammalian target of rapamycin pathway, is a key regulator
of thymus growth. In this study we will generate new mTEC tissue-specific mouse models to test the hypothesis
that paracrine fibroblast growth factor 21 (FGF21) signals are required for thymus growth and maintenance
during aging.
No Sub Projects information available for 1R21AG081709-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21AG081709-01
Patents
No Patents information available for 1R21AG081709-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21AG081709-01
Clinical Studies
No Clinical Studies information available for 1R21AG081709-01
News and More
Related News Releases
No news release information available for 1R21AG081709-01
History
No Historical information available for 1R21AG081709-01
Similar Projects
No Similar Projects information available for 1R21AG081709-01